Please select the option that best describes you:

Is it safe to deliver SBRT with concurrent immunotherapy to head and neck sites of progressive metastatic disease?  

What doses and constraints do you use?



Answer from: Radiation Oncologist at Academic Institution
Comments
Radiation Oncologist at Bon Secours Mercy Health
I too agree with Dr. @Shlomo Koyfman. SBRT in conj...
Sign in or Register to read more